Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Interpace Biosciences Inc IDXG

Healthcare
Interpace Biosciences, Inc. provides personalized medicine and offers specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Its clinical services, through Interpace Diagnostics, provide clinically useful molecular diagnostic tests, bioinformatics and pathology services for evaluating the risk of cancer by... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (OTCQX:IDXG)

Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results

GlobeNewswire March 7, 2024

Interpace Biosciences Announces Record Third Quarter 2023 Financial and Business Results

GlobeNewswire November 8, 2023

Interpace Biosciences Announces Record Second Quarter 2023 Financial and Business Results

GlobeNewswire August 9, 2023

Interpace Biosciences Releases Preliminary Record Second Quarter 2023 Business Results; Updates Status of PancraGEN® Reimbursement

GlobeNewswire July 10, 2023

Interpace Expects to Stop Offering PancraGEN® Test Due to CMS Decision to End Reimbursement as of July 17, 2023

GlobeNewswire June 5, 2023

Interpace Biosciences Announces Record First Quarter 2023 Financial and Business Results

GlobeNewswire May 12, 2023

Interpace Biosciences Announces Full Year and Fourth Quarter 2022 Financial and Business Results

GlobeNewswire March 27, 2023

Interpace Biosciences Announces Third Quarter 2022 Financial and Business Results Sale of Pharma Significantly Improves Liquidity Resulting in Removal of Going Concern

GlobeNewswire November 14, 2022

Interpace Biosciences Announces New Real-world Data; Presented at the American Thyroid Association 2022 Annual Meeting

GlobeNewswire October 20, 2022
View More News ››

Opinion & Analysis (OTCQX:IDXG)

New Data Could Drive Use of Pancreatic Cancer Early Detection Test

Streetwise Reports October 30, 2019
View More Opinion ››

Bullboard Posts (OTCQX:IDXG)

added more of this one

using dollar cost averaging for it,and it looks like an upswing is starting today,so glta.
coolfooldumbguy - December 17, 2019

it's a buy today for me

it looks like a comeback is starting,so glta.
coolfooldumbguy - June 20, 2019

Delisting not a problem yet.....

http://www.4-traders.com/INTERPACE-DIAGNOSTICS-GRO-32645693/news/INTERPACE-DIAGNOSTICS-GROUP-INC-Notice-of-Delisting-or-Failure-to...
NipNapTappy - June 24, 2018

Kinda of a new blitz on IDXG

This may go up if for no other reason than the media blitz from analysts. https://www.tipranks.com/stocks/idxg/price-target
NipNapTappy - June 24, 2018

SEC filings look decent...

http://secfilings.nasdaq.com/filingFrameset.asp?FilingID=12758821&RcvdDate=5/15/2018&CoName=INTERPACE%20DIAGNOSTICS%20GROUP%2C...
NipNapTappy - June 24, 2018

A google search confirms activity is afoot...

https://sportsperspectives.com/2018/06/24/interpace-diagnostics-group-idxg-given-coverage-optimism-rating-of-0-34.html
NipNapTappy - June 24, 2018
View more Bullboard ››

Leading Edge Materials Corp

Leading Edge Materials Corp

Leading Edge Materials Corp. is a Canada-based company, which is involved in the exploration and development of resource ...
View More »